Biogen
BIIB
970 hedge funds and large institutions have $59.1B invested in Biogen in 2015 Q4 according to their latest regulatory filings, with 139 funds opening new positions, 331 increasing their positions, 371 reducing their positions, and 82 closing their positions.
70% more first-time investments, than exits
New positions opened: 139 | Existing positions closed: 82
5% more funds holding
Funds holding: 924 → 970 (+46)
1% more capital invested
Capital invested by funds: $58.6B → $59.1B (+$451M)
0% more funds holding in top 10
Funds holding in top 10: 37 → 37 (0)
11% less repeat investments, than reductions
Existing positions increased: 331 | Existing positions reduced: 371
24% less call options, than puts
Call options by funds: $1.24B | Put options by funds: $1.63B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
D.E. Shaw & Co
New York
|
+$429M |
| 2 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$150M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
+$147M |
| 4 |
Millennium Management
New York
|
+$122M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$106M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.05B |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$292M |
| 3 |
SCM
Steadfast Capital Management
New York
|
-$224M |
| 4 |
Sands Capital Management
Arlington,
Virginia
|
-$217M |
| 5 |
DCM
Discovery Capital Management
South Norwalk,
Connecticut
|
-$204M |
BIIB Hedge Fund Activity: Q4 2015 in Review
970 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q4 2015, worth a combined $59.1B — up 0.77% from $58.6B a quarter earlier.
Buyers outnumbered sellers: 139 funds opened new BIIB positions and 82 closed out — a net gain of 57 holders — while 331 added to existing stakes and 371 trimmed.
The largest buyer was D.E. Shaw & Co, adding an estimated $429M. The largest seller was Fidelity Investments, cutting an estimated $1.05B.
- 970 institutional investors held Biogen (BIIB) as of Q4 2015, up from 924 in Q3 2015.
- Funds reported $59.1B of Biogen stock for Q4 2015, up 0.77% quarter-over-quarter.
- 139 funds opened new Biogen positions in Q4 2015 and 82 closed out, a net change of +57 holders.
- The largest Biogen buyer in Q4 2015 was D.E. Shaw & Co, an estimated $429M added.
- The largest Biogen seller in Q4 2015 was Fidelity Investments, an estimated $1.05B sold.
Based on aggregated 13F filings for Q4 2015.